Reversible Perfusion Changes during Acute Attacks in Glucose Transporter Type 1 Deficiency Syndrome: A Pediatric Case Series

References

1. 1.↵
   1. Klepper J,
   2. Akman C,
   3. Armeno M, et al

   . Glut1 deficiency syndrome (Glut1DS): state of the art in 2020 and recommendations of the international Glut1DS study group. Epilepsia Open 2020;5:354–65 doi:10.1002/epi4.12414 pmid:32913944

   CrossRefPubMed
2. 2.↵
   1. Wolking S,
   2. Becker F,
   3. Bast T, et al

   . Focal epilepsy in glucose transporter type 1 (Glut1) defects: case reports and a review of literature. J Neurol 2014;261:1881–86 doi:10.1007/s00415-014-7433-5 pmid:25022942

   CrossRefPubMed
3. 3.↵
   1. Verrotti A,
   2. D’Egidio C,
   3. Agostinelli S, et al

   . Glut1 deficiency: when to suspect and how to diagnose? Eur J Paediatr Neurol 2012;16:3–9 doi:10.1016/j.ejpn.2011.09.005 pmid:21962875

   CrossRefPubMed
4. 4.↵
   1. Vaudano AE,
   2. Olivotto S,
   3. Ruggieri A, et al

   . Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome. Neuroimage Clin 2017;13:446–54 doi:10.1016/j.nicl.2016.12.026 pmid:28116237

   CrossRefPubMed
5. 5.↵
   1. Leary LD,
   2. Wang D,
   3. Nordli DR, Jr., et al

   . Seizure characterization and electroencephalographic features in Glut‐1 deficiency syndrome. Epilepsia 2003;44:701–07 doi:10.1046/j.1528-1157.2003.05302.x pmid:12752470

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Kolic I,
   2. Radic Nisevic J,
   3. Vlasic Cicvaric I, et al

   . GLUT1 deficiency syndrome: early treatment maintains cognitive development? (literature review and case report). Genes (Basel) 2021;12:1379 doi:10.3390/genes12091379 pmid:34573360

   CrossRefPubMed
7. 7.↵
   1. De Giorgis V,
   2. Veggiotti P

   . GLUT1 deficiency syndrome 2013: current state of the art. Seizure 2013;22:803–11 doi:10.1016/j.seizure.2013.07.003 pmid:23890838

   CrossRefPubMed
8. 8.↵
   1. Olivotto S,
   2. Freddi A,
   3. Previtali R, et al

   . Stroke and stroke-like episodes: recurrent manifestations in GLUT1 deficiency syndrome. Pediatr Neurol 2024;157:118–26 doi:10.1016/j.pediatrneurol.2024.05.024 pmid:38914025

   CrossRefPubMed
9. 9.↵
   1. Schwantje M,
   2. Verhagen LM,
   3. van Hasselt PM, et al

   . Glucose transporter type 1 deficiency syndrome and the ketogenic diet. J Inherit Metab Dis 2020;43:216–22 doi:10.1002/jimd.12175 pmid:31605543

   CrossRefPubMed
10. 10.↵
    1. Veys K,
    2. Fan Z,
    3. Ghobrial M, et al

    . Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood-brain barrier integrity. Circ Res 2020;127:466–82 doi:10.1161/CIRCRESAHA.119.316463 pmid:32404031

    CrossRefPubMed
11. 11.↵
    1. Winczewska-Wiktor A,
    2. Hoffman-Zacharska D,
    3. Starczewska M, et al

    . Variety of symptoms of GLUT1 deficiency syndrome in three-generation family. Epilepsy Behav 2020;106:107036 doi:10.1016/j.yebeh.2020.107036 pmid:32247176

    CrossRefPubMed
12. 12.↵
    1. Klepper J,
    2. Engelbrecht V,
    3. Scheffer H, et al

    . GLUT1 deficiency with delayed myelination responding to ketogenic diet. Pediatr Neurol 2007;37:130–33 doi:10.1016/j.pediatrneurol.2007.03.009 pmid:17675029

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Pawlik W,
    2. Okulewicz P,
    3. Pawlik J, et al

    . Diagnostic and clinical manifestation differences of glucose transporter type 1 deficiency syndrome in a family with SLC2A1 gene mutation. Int J Environ Res Public Health 2022;19:3279 doi:10.3390/ijerph19063279 pmid:35328965

    CrossRefPubMed
14. 14.↵
    1. Santarone ME,
    2. Piscitello LM,
    3. Volponi C, et al

    . Focal non-motor seizures and subsequent focal motor seizures as the main clinical expression of GLUT-1 deficiency. Epilepsy Behav Rep 2022;20:100571 doi:10.1016/j.ebr.2022.100571 pmid:36439032

    CrossRefPubMed
15. 15.↵
    1. Kim H,
    2. Lee JS,
    3. Lee Y, et al

    . Diagnostic challenges associated with GLUT1 deficiency: phenotypic variabilities and evolving clinical features. Yonsei Med J 2019;60:1209–15 doi:10.3349/ymj.2019.60.12.1209 pmid:31769253

    CrossRefPubMed
16. 16.↵
    1. Almuqbil M,
    2. Rivkin MJ,
    3. Takeoka M, et al

    . Transient regional cerebral hypoperfusion during a paroxysmal hemiplegic event in GLUT1 deficiency syndrome. Eur J Paediatr Neurol 2018;22:544–47 doi:10.1016/j.ejpn.2018.02.005 pmid:29500071

    CrossRefPubMed
17. 17.↵
    1. Kumar A,
    2. Samanta D,
    3. Emmady PD, et al

    . Hemiplegic migraine. Treasure Island, FL, USA: StatPearls Publishing, 2024
18. 18.↵
    1. Safier R,
    2. Cleves-Bayon C,
    3. Vaisleib I, et al

    . Magnetic resonance angiography evidence of vasospasm in children with suspected acute hemiplegic migraine. J Child Neurol 2014;29:789–92 doi:10.1177/0883073813483364 pmid:23594822

    CrossRefPubMed
19. 19.↵
    1. Eikermann-Haerter K,
    2. Ayata C

    . Cortical spreading depression and migraine. Curr Neurol Neurosci Rep 2010;10:167–73 doi:10.1007/s11910-010-0099-1 pmid:20425031

    CrossRefPubMed
20. 20.↵
    1. Pellegrin S,
    2. Cantalupo G,
    3. Opri R, et al

    . EEG findings during “paroxysmal hemiplegia” in a patient with GLUT1-deficiency. Eur J Paediatr Neurol 2017;21:580–82 doi:10.1016/j.ejpn.2017.01.002 pmid:28129950

    CrossRefPubMed
21. 21.↵
    1. Harriott AM,
    2. Takizawa T,
    3. Chung DY, et al

    . Spreading depression as a preclinical model of migraine. J Headache Pain 2019;20:45 doi:10.1186/s10194-019-1001-4 pmid:31046659

    CrossRefPubMed
22. 22.↵
    1. Russo A,
    2. Silvestro M,
    3. Tessitore A, et al

    . Arterial spin labeling MRI applied to migraine: current insights and future perspectives. J Headache Pain 2023;24:71 doi:10.1186/s10194-023-01597-y pmid:37322466

    CrossRefPubMed
23. 23.↵
    1. Nersesyan N,
    2. Arnold S,
    3. Krieg P

    . Susceptibility-weighted imaging findings in patients suffering from migraine with aura. Clin Neuroradiol 2019;29:783–85 doi:10.1007/s00062-019-00775-3 pmid:30887092

    CrossRefPubMed
24. 24.↵
    1. Zhu Y,
    2. Ruan G,
    3. Cheng Z, et al

    . Lateralization of the crossed cerebellar diaschisis-associated metabolic connectivities in cortico-ponto-cerebellar and cortico-rubral pathways. Neuroimage 2022;260:119487 doi:10.1016/j.neuroimage.2022.119487 pmid:35850160

    CrossRefPubMed
25. 25.↵
    1. Kellner-Weldon F,
    2. El-Koussy M,
    3. Jung S, et al

    . Cerebellar hypoperfusion in migraine attack: incidence and significance. AJNR Am J Neuroradiol 2018;39:435–40 doi:10.3174/ajnr.A5508 pmid:29326138

    Abstract/FREE Full Text
26. 26.↵
    1. Gburek‐Augustat J,
    2. Heinze A,
    3. Abou Jamra R, et al

    . Hemiplegic migraine in glut1 deficiency syndrome and paroxysmal dyskinesia at ketogenic diet induction: case report and literature review. Mov Disord Clin Pract 2020;7:965–70 doi:10.1002/mdc3.13087 pmid:33163569

    CrossRefPubMed
27. 27.↵
    1. Mohammad SS,
    2. Coman D,
    3. Calvert S

    . Glucose transporter 1 deficiency syndrome and hemiplegic migraines as a dominant presenting clinical feature. J Paediatr Child Health 2014;50:1025–26 doi:10.1111/jpc.12613 pmid:25440161

    CrossRefPubMed
28. 28.↵
    1. Pons R,
    2. Collins A,
    3. Rotstein M, et al

    . The spectrum of movement disorders in Glut‐1 deficiency. Mov Disord 2010;25:275–81 doi:10.1002/mds.22808 pmid:20063428

    CrossRefPubMed
29. 29.↵
    1. Alsop DC,
    2. Detre JA,
    3. Golay X, et al

    . Recommended implementation of arterial spin‐labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed
30. 30.↵
    1. Amukotuwa SA,
    2. Yu C,
    3. Zaharchuk G

    . 3D Pseudocontinuous arterial spin labeling in routine clinical practice: a review of clinically significant artifacts. J Magn Reson Imaging 2016;43:11–27 doi:10.1002/jmri.24873 pmid:25857715

    CrossRefPubMed